Cyclerion Therapeutics (CYCN) Assets Average (2019 - 2025)
Cyclerion Therapeutics (CYCN) has 7 years of Assets Average data on record, last reported at $9.9 million in Q3 2025.
- For Q3 2025, Assets Average rose 4.33% year-over-year to $9.9 million; the TTM value through Sep 2025 reached $9.9 million, up 4.33%, while the annual FY2024 figure was $11.5 million, 27.04% down from the prior year.
- Assets Average reached $9.9 million in Q3 2025 per CYCN's latest filing, up from $9.6 million in the prior quarter.
- Across five years, Assets Average topped out at $107.7 million in Q1 2021 and bottomed at $9.2 million in Q4 2024.
- Average Assets Average over 5 years is $31.6 million, with a median of $14.3 million recorded in 2023.
- Peak YoY movement for Assets Average: tumbled 73.63% in 2023, then rose 4.33% in 2025.
- A 5-year view of Assets Average shows it stood at $63.5 million in 2021, then crashed by 66.06% to $21.6 million in 2022, then plummeted by 33.72% to $14.3 million in 2023, then plummeted by 35.38% to $9.2 million in 2024, then grew by 7.1% to $9.9 million in 2025.
- Per Business Quant database, its latest 3 readings for Assets Average were $9.9 million in Q3 2025, $9.6 million in Q2 2025, and $9.7 million in Q1 2025.